Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Clinical trial NCT01722305 · COMPLETED

Trial details

NCT number: NCT01722305
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma Central Nervous System Lymphoma Intraocular Lymphoma Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Recurrent Adult Diffuse Large Cell Lymphoma Retinal Lymphoma

Start date: 2013-04-08
Primary completion: 2016-06-03
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.